Qianhai Health Holdings Limited (0911.HK)

HKD 0.27

(0.0%)

Market Cap (In HKD)

45.75 Million

Revenue (In HKD)

961.29 Million

Net Income (In HKD)

-52.7 Million

Avg. Volume

83.98 Thousand

Currency
HKD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.138-0.72
PE
-
EPS
-
Beta Value
0.094
ISIN
KYG7307F1046
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Chee Lap Yuen
Employee Count
-
Website
https://www.qianhaihealth.com.hk
Ipo Date
2014-06-27
Details
Qianhai Health Holdings Limited, an investment holding company, engages in the sale of health products and electronic component products in Hong Kong. The company operates through Health-Care Products and Electronic Component Products segments. It offers Chinese herbal medicines, and skincare and other health-care products to wholesalers and retailers, as well as American ginseng, a perennial plant. The company is also involved in the sale of electronic components, including central processing unit, semi-conductor, etc. In addition, it engages in the trading of health-care products and electronic components; and money lending business. The company was formerly known as Hang Fat Ginseng Holdings Company Limited and changed its name to Qianhai Health Holdings Limited in September 2016. The company was founded in 1989 and is based in Sheung Wan, Hong Kong. Qianhai Health Holdings Limited is a subsidiary of Explorer Rosy Limited.